University of Iowa Hospitals and Clinics
A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Effect of Vandetanib on Cellular Markers of Proliferation and Apoptosis in Invasive Breast Cancer
Participants in this research study have been diagnosed with breast cancer. The purpose of this research study is to test the effectiveness of a drug called Vandetanib on tumor growth markers. Vandetanib is currently used to treat a specific, rare type thyroid cancer. It is not approved for use in breast cancer so its use in this study is considered experimental. Previous research suggests that it may have anti-breast cancer activity. Approximately 80 people will take part in this study conducted by investigators at the University of Iowa.
Michelle Arnold, (319) 356-2778
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.